BMRN logo

BioMarin Pharmaceutical (BMRN) Depreciation and amortization

annual D&A:

$96.43M-$7.96M(-7.63%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual depreciation & amortization is $96.43 million, with the most recent change of -$7.96 million (-7.63%) on December 31, 2024.
  • During the last 3 years, BMRN annual D&A has fallen by -$11.61 million (-10.75%).
  • BMRN annual D&A is now -10.75% below its all-time high of $108.04 million, reached on December 31, 2021.

Performance

BMRN Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly D&A:

$22.07M-$1.54M(-6.52%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly depreciation & amortization is $22.07 million, with the most recent change of -$1.54 million (-6.52%) on March 31, 2025.
  • Over the past year, BMRN quarterly D&A has dropped by -$5.28 million (-19.31%).
  • BMRN quarterly D&A is now -28.21% below its all-time high of $30.74 million, reached on September 30, 2019.

Performance

BMRN quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM D&A:

$91.14M-$5.28M(-5.48%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN TTM depreciation & amortization is $91.14 million, with the most recent change of -$5.28 million (-5.48%) on March 31, 2025.
  • Over the past year, BMRN TTM D&A has dropped by -$14.17 million (-13.45%).
  • BMRN TTM D&A is now -16.69% below its all-time high of $109.41 million, reached on September 30, 2021.

Performance

BMRN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

BMRN Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.6%-19.3%-13.4%
3 y3 years-10.8%-19.3%-15.1%
5 y5 years-8.4%-15.0%-15.4%

BMRN Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.8%at low-19.3%+16.1%-14.3%at low
5 y5-year-10.8%at low-21.1%+16.1%-16.7%at low
alltimeall time-10.8%>+9999.0%-28.2%+1557.7%-16.7%+9115.9%

BMRN Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$22.07M(-6.5%)
$91.14M(-5.5%)
Dec 2024
$96.43M(-7.6%)
$23.61M(+24.2%)
$96.43M(-3.3%)
Sep 2024
-
$19.01M(-28.2%)
$99.68M(-6.3%)
Jun 2024
-
$26.46M(-3.2%)
$106.36M(+1.0%)
Mar 2024
-
$27.35M(+1.8%)
$105.31M(+0.9%)
Dec 2023
$104.39M(+2.4%)
$26.86M(+4.6%)
$104.39M(+2.3%)
Sep 2023
-
$25.68M(+1.0%)
$102.08M(+0.9%)
Jun 2023
-
$25.42M(-3.8%)
$101.19M(+0.1%)
Mar 2023
-
$26.42M(+7.6%)
$101.05M(-0.9%)
Dec 2022
$101.97M(-5.6%)
$24.55M(-1.0%)
$101.97M(-1.4%)
Sep 2022
-
$24.80M(-1.9%)
$103.40M(-1.9%)
Jun 2022
-
$25.27M(-7.6%)
$105.44M(-1.8%)
Mar 2022
-
$27.34M(+5.2%)
$107.40M(-0.6%)
Dec 2021
$108.04M(+2.7%)
$25.99M(-3.2%)
$108.04M(-1.3%)
Sep 2021
-
$26.84M(-1.4%)
$109.41M(+0.2%)
Jun 2021
-
$27.23M(-2.7%)
$109.21M(+1.9%)
Mar 2021
-
$27.98M(+2.3%)
$107.19M(+1.9%)
Dec 2020
$105.17M(-0.1%)
$27.36M(+2.7%)
$105.17M(+1.5%)
Sep 2020
-
$26.63M(+5.6%)
$103.60M(-3.8%)
Jun 2020
-
$25.22M(-2.9%)
$107.71M(-1.0%)
Mar 2020
-
$25.96M(+0.7%)
$108.84M(+3.4%)
Dec 2019
$105.30M(+10.1%)
$25.79M(-16.1%)
$105.30M(+1.0%)
Sep 2019
-
$30.74M(+16.7%)
$104.23M(+4.4%)
Jun 2019
-
$26.34M(+17.5%)
$99.83M(+5.7%)
Mar 2019
-
$22.43M(-9.3%)
$94.47M(-1.3%)
Dec 2018
$95.67M(+8.9%)
$24.72M(-6.2%)
$95.67M(-4.0%)
Sep 2018
-
$26.34M(+25.6%)
$99.62M(+6.0%)
Jun 2018
-
$20.98M(-11.2%)
$93.97M(+2.1%)
Mar 2018
-
$23.63M(-17.6%)
$92.08M(+4.8%)
Dec 2017
$87.86M(-9.3%)
$28.66M(+38.5%)
$87.86M(+10.8%)
Sep 2017
-
$20.70M(+8.5%)
$79.30M(-9.9%)
Jun 2017
-
$19.09M(-1.7%)
$88.03M(-9.8%)
Mar 2017
-
$19.41M(-3.5%)
$97.60M(+0.7%)
Dec 2016
$96.91M(+105.4%)
$20.11M(-31.7%)
$96.91M(+8.1%)
Sep 2016
-
$29.42M(+2.7%)
$89.69M(+24.0%)
Jun 2016
-
$28.66M(+53.0%)
$72.31M(+31.2%)
Mar 2016
-
$18.73M(+45.3%)
$55.10M(+16.8%)
Dec 2015
$47.19M(+2.9%)
$12.89M(+7.0%)
$47.19M(+17.2%)
Sep 2015
-
$12.04M(+5.2%)
$40.27M(-5.2%)
Jun 2015
-
$11.45M(+5.8%)
$42.45M(-5.0%)
Mar 2015
-
$10.82M(+81.3%)
$44.68M(-2.6%)
Dec 2014
$45.87M(+27.4%)
$5.97M(-58.1%)
$45.87M(+19.5%)
Sep 2014
-
$14.22M(+4.0%)
$38.39M(+2.4%)
Jun 2014
-
$13.68M(+13.9%)
$37.48M(+2.2%)
Mar 2014
-
$12.00M(-892.9%)
$36.67M(+1.8%)
Dec 2013
$36.01M(-18.8%)
-$1.51M(-111.4%)
$36.01M(-25.6%)
Sep 2013
-
$13.31M(+3.5%)
$48.42M(+3.5%)
Jun 2013
-
$12.87M(+13.4%)
$46.78M(+3.8%)
Mar 2013
-
$11.35M(+4.1%)
$45.09M(+1.7%)
Dec 2012
$44.34M(+26.5%)
$10.90M(-6.6%)
$44.34M(+5.5%)
Sep 2012
-
$11.67M(+4.4%)
$42.02M(+5.8%)
Jun 2012
-
$11.17M(+5.4%)
$39.70M(+7.1%)
Mar 2012
-
$10.60M(+23.5%)
$37.06M(+5.7%)
DateAnnualQuarterlyTTM
Dec 2011
$35.05M(+26.4%)
$8.58M(-8.2%)
$35.05M(+1.9%)
Sep 2011
-
$9.35M(+9.6%)
$34.40M(+4.7%)
Jun 2011
-
$8.53M(-0.6%)
$32.87M(+6.3%)
Mar 2011
-
$8.59M(+8.2%)
$30.91M(+11.4%)
Dec 2010
$27.74M(+32.2%)
$7.93M(+1.4%)
$27.74M(+12.4%)
Sep 2010
-
$7.82M(+18.9%)
$24.67M(+13.7%)
Jun 2010
-
$6.58M(+21.6%)
$21.69M(+1.9%)
Mar 2010
-
$5.41M(+11.3%)
$21.28M(+1.5%)
Dec 2009
$20.98M(+19.1%)
$4.86M(+0.4%)
$20.98M(+0.6%)
Sep 2009
-
$4.84M(-21.5%)
$20.86M(-16.1%)
Jun 2009
-
$6.17M(+20.9%)
$24.85M(+14.6%)
Mar 2009
-
$5.10M(+7.6%)
$21.69M(+23.1%)
Dec 2008
$17.62M(+1516.1%)
$4.74M(-46.3%)
$17.62M(+35.2%)
Sep 2008
-
$8.84M(+193.8%)
$13.03M(+214.1%)
Jun 2008
-
$3.01M(+191.7%)
$4.15M(+224.6%)
Mar 2008
-
$1.03M(+556.7%)
$1.28M(+17.2%)
Dec 2007
$1.09M(-88.9%)
$157.00K(-441.3%)
$1.09M(-17.9%)
Sep 2007
-
-$46.00K(-133.8%)
$1.33M(-70.2%)
Jun 2007
-
$136.00K(-83.9%)
$4.46M(-44.9%)
Mar 2007
-
$843.00K(+114.0%)
$8.10M(-17.3%)
Dec 2006
$9.79M(+0.4%)
$394.00K(-87.2%)
$9.79M(-17.3%)
Sep 2006
-
$3.09M(-18.3%)
$11.85M(+5.9%)
Jun 2006
-
$3.78M(+49.0%)
$11.19M(+14.0%)
Mar 2006
-
$2.54M(+3.6%)
$9.82M(+0.7%)
Dec 2005
$9.75M(-26.6%)
$2.45M(+0.8%)
$9.75M(-25.4%)
Sep 2005
-
$2.43M(+1.0%)
$13.06M(+2.1%)
Jun 2005
-
$2.40M(-2.5%)
$12.79M(-5.7%)
Mar 2005
-
$2.47M(-57.2%)
$13.55M(+2.1%)
Dec 2004
$13.28M(+40.6%)
$5.76M(+167.1%)
$13.28M(+34.1%)
Sep 2004
-
$2.16M(-32.1%)
$9.90M(-7.3%)
Jun 2004
-
$3.17M(+44.8%)
$10.68M(+11.9%)
Mar 2004
-
$2.19M(-8.1%)
$9.55M(+1.1%)
Dec 2003
$9.44M(+11.0%)
$2.38M(-18.7%)
$9.44M(+5.6%)
Sep 2003
-
$2.93M(+43.7%)
$8.94M(+6.6%)
Jun 2003
-
$2.04M(-2.2%)
$8.39M(-1.6%)
Mar 2003
-
$2.08M(+10.7%)
$8.53M(+0.3%)
Dec 2002
$8.50M(+21.4%)
$1.88M(-20.9%)
$8.50M(+14.0%)
Sep 2002
-
$2.38M(+9.3%)
$7.46M(+2.4%)
Jun 2002
-
$2.18M(+5.7%)
$7.28M(+1.6%)
Mar 2002
-
$2.06M(+145.6%)
$7.17M(+2.3%)
Dec 2001
$7.00M(+22.2%)
$839.00K(-61.9%)
$7.00M(+6.8%)
Sep 2001
-
$2.20M(+6.8%)
$6.56M(+4.7%)
Jun 2001
-
$2.06M(+8.5%)
$6.26M(+6.2%)
Mar 2001
-
$1.90M(+381.0%)
$5.90M(+2.9%)
Dec 2000
$5.73M(+5.9%)
$395.00K(-79.3%)
$5.73M(-12.5%)
Sep 2000
-
$1.91M(+12.4%)
$6.55M(-1.4%)
Jun 2000
-
$1.70M(-2.1%)
$6.65M(+7.9%)
Mar 2000
-
$1.73M(+42.7%)
$6.16M(+13.8%)
Dec 1999
$5.42M(+576.9%)
$1.22M(-39.3%)
$5.42M(+28.9%)
Sep 1999
-
$2.00M(+65.2%)
$4.20M(+90.9%)
Jun 1999
-
$1.21M(+22.4%)
$2.20M(+122.4%)
Mar 1999
-
$989.00K
$989.00K
Dec 1998
$800.00K
-
-

FAQ

  • What is BioMarin Pharmaceutical annual depreciation & amortization?
  • What is the all time high annual D&A for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual D&A year-on-year change?
  • What is BioMarin Pharmaceutical quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly D&A year-on-year change?
  • What is BioMarin Pharmaceutical TTM depreciation & amortization?
  • What is the all time high TTM D&A for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM D&A year-on-year change?

What is BioMarin Pharmaceutical annual depreciation & amortization?

The current annual D&A of BMRN is $96.43M

What is the all time high annual D&A for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual depreciation & amortization is $108.04M

What is BioMarin Pharmaceutical annual D&A year-on-year change?

Over the past year, BMRN annual depreciation & amortization has changed by -$7.96M (-7.63%)

What is BioMarin Pharmaceutical quarterly depreciation & amortization?

The current quarterly D&A of BMRN is $22.07M

What is the all time high quarterly D&A for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly depreciation & amortization is $30.74M

What is BioMarin Pharmaceutical quarterly D&A year-on-year change?

Over the past year, BMRN quarterly depreciation & amortization has changed by -$5.28M (-19.31%)

What is BioMarin Pharmaceutical TTM depreciation & amortization?

The current TTM D&A of BMRN is $91.14M

What is the all time high TTM D&A for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM depreciation & amortization is $109.41M

What is BioMarin Pharmaceutical TTM D&A year-on-year change?

Over the past year, BMRN TTM depreciation & amortization has changed by -$14.17M (-13.45%)
On this page